Jarkko Rautio
University of Eastern Finland
School of Pharmacy
FI-70211 Kuopio
Finland
Name/email consistency: high
- Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-O-methyltransferase inhibitor. Rautio, J., Leppänen, J., Lehtonen, M., Laine, K., Koskinen, M., Pystynen, J., Savolainen, J., Sairanen, M. Bioorg. Med. Chem. Lett. (2010)
- Prodrug approaches for CNS delivery. Rautio, J., Laine, K., Gynther, M., Savolainen, J. AAPS. J (2008)
- Prodrugs: design and clinical applications. Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., Savolainen, J. Nat. Rev. Drug. Discov (2008)
- Drug delivery systems for brain tumor therapy. Rautioa, J., Chikhale, P.J. Curr. Pharm. Des. (2004)
- Synthesis and in vitro evaluation of novel morpholinyl- and methylpiperazinylacyloxyalkyl prodrugs of 2-(6-methoxy-2-naphthyl)propionic acid (Naproxen) for topical drug delivery. Rautio, J., Nevalainen, T., Taipale, H., Vepsäläinen, J., Gynther, J., Laine, K., Järvinen, T. J. Med. Chem. (2000)
- Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. Rautio, J., Nevalainen, T., Taipale, H., Vepsäläinen, J., Gynther, J., Laine, K., Järvinen, T. Eur. J. Pharm. Sci (2000)
- Synthesis and in vitro evaluation of aminoacyloxyalkyl esters of 2-(6-methoxy-2-naphthyl)propionic acid as novel naproxen prodrugs for dermal drug delivery. Rautio, J., Nevalainen, T., Taipale, H., Vepsäläinen, J., Gynther, J., Pedersen, T., Järvinen, T. Pharm. Res. (1999)
- In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. Rautio, J., Taipale, H., Gynther, J., Vepsalainen, J., Nevalainen, T., Jarvinen, T. J. Pharm. Sci (1998)
